BioInvent International AB (publ) (LON:0H22)
 33.50
 +3.05 (10.02%)
  At close: Oct 30, 2025
BioInvent International AB Employees
BioInvent International AB had 114 employees as of December 31, 2024. The number of employees increased by 3 or 2.70% compared to the previous year.
Employees 
 114
Change (1Y) 
 3
Growth (1Y) 
 2.70%
Revenue / Employee 
 158.45K GBP
Profits / Employee 
 -209.63K GBP
Market Cap 
176.70M
Employees Chart
Employees History
| Date | Employees | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 114 | 3 | 2.70% | 
| Dec 31, 2023 | 111 | 17 | 18.09% | 
| Dec 31, 2022 | 94 | 10 | 11.90% | 
| Dec 31, 2021 | 84 | 12 | 16.67% | 
| Dec 31, 2020 | 72 | 0 | - | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Related Stocks
| Company Name | Employees | 
|---|---|
| AstraZeneca | 94,300 | 
| GSK plc | 68,629 | 
| Haleon | 24,561 | 
| Smith & Nephew | 17,349 | 
| Spire Healthcare Group | 15,703 | 
| ConvaTec Group | 10,489 | 
| Hikma Pharmaceuticals | 9,500 | 
| Genus | 3,190 |